After a string of regulatory mishaps including loose oversight of money-laundering controls, JPM is taking no chances.» Read More
Most analysts believe the market is due for a modest correction, but many traders are reluctant to sell in the face of strong earnings, massive liquidity and daily deals. "I don't think there's anything to be that bearish about," Stephen Leeb, research chairman for The Complete Investor, told CNBC.com. "There's no recession, valuations are basically very reasonable and there are massive amounts of cash on the sidelines."
Here’s the final trade: our guys give you tomorrow's best trades tonight.
Jeff from California asked whether Healthcare is an essential sector to own for diversification or are there other "recession-proof" sectors that can take it's place, since biotech is dicey and big pharma's pipeline is weak?